Exact Mass: 411.163

Exact Mass Matches: 411.163

Found 76 metabolites which its exact mass value is equals to given mass value 411.163, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

COELENTERAMIDE

Oxidized Oplophorus luciferin

C25H21N3O3 (411.1583)

Ro 18-5364

5,7-Dihydro-2-(((4-methoxy-3-methyl-2-pyridyl)methyl)sulfinyl)-5,5,7,7-tetramethylindeno(5,6-d)imidazol-6(1H)-one

C22H25N3O3S (411.1617)

7-Formyldehydrothalicsimidine

4,5,14,15,16-pentamethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2(7),3,5,8,13(17),14-heptaene-8-carbaldehyde

C23H25NO6 (411.1682)

7-Formyldehydrothalicsimidine is found in beverages. 7-Formyldehydrothalicsimidine is an alkaloid from Annona purpurea (soncoya). Alkaloid from Annona purpurea (soncoya). 7-Formyldehydrothalicsimidine is found in beverages and fruits.

Magon

N-(2,4-dimethylphenyl)-3-hydroxy-4-[2-(2-hydroxyphenyl)diazen-1-yl]naphthalene-2-carboxamide

C25H21N3O3 (411.1583)

PKCbeta Inhibitor

3-{1-[3-(1H-imidazol-1-yl)propyl]-1H-indol-3-yl}-4-(phenylamino)-2,5-dihydro-1H-pyrrole-2,5-dione

C24H21N5O2 (411.1695)

N-(2(S)-(Acetylthiomethyl)-3-(2-methylphenyl)-1-oxopropyl)-L-methionine ethyl ester

3-(Acetylsulphanyl)-N-[1-ethoxy-4-(methylsulphanyl)-1-oxobutan-2-yl]-2-[(2-methylphenyl)methyl]propanimidic acid

C20H29NO4S2 (411.1538)

FR 900452

C22H25N3O3S (411.1617)

Fumaricine acetate

(-)-O-Methylfumarophycine

C23H25NO6 (411.1682)

7-Formyldehydrothalicsimidine

4,5,14,15,16-pentamethoxy-10-methyl-10-azatetracyclo[7.7.1.0^{2,7}.0^{13,17}]heptadeca-1(16),2,4,6,8,13(17),14-heptaene-8-carbaldehyde

C23H25NO6 (411.1682)

6-HydroxyKetanserin

C22H22FN3O4 (411.1594)

2-N,N-bis(tert-Butoxycarbonyl)amino-4,5,6,7-tetrahydro-benzo[b]thiophene-3-carboxylic acid Methyl ester

C20H29NO6S (411.1715)

3-[3-(3-hydroxy-2-phenylpropanoyl)oxy-8-methyl-8-azoniabicyclo[3.2.1]octan-8-yl]propane-1-sulfonate

C20H29NO6S (411.1715)

3-Butyl-1,1,2-trimethyl-1H-benzo[e]indolium hexafluorophosphate

C19H24F6NP (411.155)

FMOC-ASP(OTBU)-OH

C23H25NO6 (411.1682)

2-Methyl-2-propanyl (3Z,5Z)-3,5-bis(4-fluorobenzylidene)-4-oxo-1- piperidinecarboxylate

C24H23F2NO3 (411.1646)

JAK2 inhibitor G5-7

C24H23F2NO3 (411.1646)

fmoc-d-aspartic acid β-tert-butyl ester

C23H25NO6 (411.1682)

Fmoc-Asp-OtBu

C23H25NO6 (411.1682)

Fmoc-D-Asp(OtBu)-OH

C23H25NO6 (411.1682)

Fmoc-D-Asu-OH

C23H25NO6 (411.1682)

fmoc-asu-oh

C23H25NO6 (411.1682)

Methyl 1-((2-cyano-[1,1-biphenyl]-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylate

C25H21N3O3 (411.1583)

2-[(2-cyanoethyl)[4-[(2-hydroxy-4-nitrophenyl)azo]-m-tolyl]amino]ethyl acetate

C20H21N5O5 (411.1543)

(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-4-[(2-methylpropan-2-yl)oxy]-4-oxobutanoic acid

C23H25NO6 (411.1682)

Fmoc-nAsp(OtBu)-OH

C23H25NO6 (411.1682)

BOC-ASP-OFM

C23H25NO6 (411.1682)

PKCβ inhibitor 1

PKCbeta Inhibitor

C24H21N5O2 (411.1695)

Boc-asp(ofm)-oh

C23H25NO6 (411.1682)

Bimiralisib

C17H20F3N7O2 (411.163)

C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2152 - Phosphatidylinositide 3-Kinase Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor Bimiralisib (PQR309) is a potent, brain-penetrant, orally bioavailable, pan-class I PI3K/mTOR inhibitor with IC50s of 33 nM, 451 nM, 661 nM, 708 nM and 89 nM for PI3Kα, PI3Kδ, PI3Kβ, PI3Kγ and mTOR, respectively. Bimiralisib is an mTORC1 and mTORC2 inhibitor. Bimiralisib (PQR309) is a potent, brain-penetrant, orally bioavailable, pan-class I PI3K/mTOR inhibitor with IC50s of 33 nM, 451 nM, 661 nM, 708 nM and 89 nM for PI3Kα, PI3Kδ, PI3Kβ, PI3Kγ and mTOR, respectively. Bimiralisib is an mTORC1 and mTORC2 inhibitor.

3-[(1s)-1-[(5r)-6-hydroxy-5-[(methylsulfanyl)methyl]-3-[(1e)-2-oxocyclopent-3-en-1-ylidene]-4,5-dihydro-2h-pyrazin-2-yl]ethyl]-1-methyl-3h-indol-2-one

C22H25N3O3S (411.1617)

(3s)-3-[(1s)-1-[(2s,5r)-6-hydroxy-5-[(methylsulfanyl)methyl]-3-[(1z)-2-oxocyclopent-3-en-1-ylidene]-4,5-dihydro-2h-pyrazin-2-yl]ethyl]-1-methyl-3h-indol-2-one

C22H25N3O3S (411.1617)

(7s,8r)-6',7'-dimethoxy-2'-methyl-3',4',6,8-tetrahydro-2h-spiro[indeno[4,5-d][1,3]dioxole-7,1'-isoquinolin]-8-yl acetate

C23H25NO6 (411.1682)

3-(1-{6-hydroxy-5-[(methylsulfanyl)methyl]-3-(2-oxocyclopent-3-en-1-ylidene)-4,5-dihydro-2h-pyrazin-2-yl}ethyl)-1-methyl-3h-indol-2-one

C22H25N3O3S (411.1617)

(3s)-3-[(1s)-1-[(2s,5r)-6-hydroxy-5-[(methylsulfanyl)methyl]-3-[(1e)-2-oxocyclopent-3-en-1-ylidene]-4,5-dihydro-2h-pyrazin-2-yl]ethyl]-1-methyl-3h-indol-2-one

C22H25N3O3S (411.1617)

2-amino-n-{5-[6-(dimethylamino)purin-9-yl]-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl}-3-(methylsulfanyl)propanimidic acid

C16H25N7O4S (411.1689)

methyl (2s,3s,5s,6r,10s)-3,5-dihydroxy-2,6-dimethyl-21-oxo-14-oxa-8-azahexacyclo[11.6.1.1⁵,¹⁹.0²,¹⁰.0³,⁸.0¹⁷,²⁰]henicosa-1(19),13(20),15,17-tetraene-18-carboxylate

C23H25NO6 (411.1682)

(2r)-2-amino-n-[(3s,4r)-5-[6-(dimethylamino)purin-9-yl]-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]-3-(methylsulfanyl)propanimidic acid

C16H25N7O4S (411.1689)

2-[(2r,4r,5s,6r)-4-(dimethylamino)-5-hydroxy-6-methyloxan-2-yl]-1,6-dihydroxy-8-methylanthracene-9,10-dione

C23H25NO6 (411.1682)